Acotiamide Hydrochloride Hydrate Er Tablets 300 mg
Acotiamide is a novel gastroprokinetic drug that exerts its activity via muscarinic receptor inhibition, which results in enhanced acetylcholine release, and via inhibition of acetylcholinesterase (AChE) activity in the stomach Acotiamide is significantly effective in elimination of major cardinal symptoms of Post prandial distress syndrome (PDS ) such as postprandial fullness, upper abdominal bloating, and early satiety. Acotiamide is well-tolerated and safe for continuous long term use of even up to 1 year, in patients with Functional Dyspepsia. Unique Technological Benefit of ACOTOP ER as Extended Release Tablet has scoring benefits over conventional Acotiamide 100 mg as it reduced pill burden from T.I.D. to O.D.